Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
-15,300
Closed -$608K 2383
2015
Q2
$608K Sell
15,300
-2,900
-16% -$90.4K ﹤0.01% 1800
2015
Q1
$487K Buy
+18,200
New +$513K ﹤0.01% 1817
2014
Q3
Sell
-12,800
Closed -$214K 2551
2014
Q2
$214K Sell
12,800
-16,900
-57% -$239K ﹤0.01% 2625
2014
Q1
$442K Buy
29,700
+10,900
+58% +$168K ﹤0.01% 2117
2013
Q4
$275K Sell
18,800
-2,300
-11% -$37K ﹤0.01% 2676
2013
Q3
$363K Buy
21,100
+6,300
+43% +$93.5K ﹤0.01% 2656
2013
Q2
$172K Buy
+14,800
New +$170K ﹤0.01% 3050

Other funds holding AMED

Timber Hill's AMED Position: Q1 2014 in Review

Timber Hill sold out of Amedisys (AMED) in Q1 2014, closing a stake of 15,243 shares — an estimated $235K sold.

Timber Hill first reported a position in AMED in Q4 2013 and held it in 1 quarter. The position peaked at $223K in Q4 2013. 120 funds tracked by Wall St. Rank hold AMED as of Q1 2014.

  • Timber Hill reported no remaining Amedisys position as of Q1 2014 after selling out during the quarter.
  • Timber Hill sold 15,243 Amedisys shares in Q1 2014, an estimated $235K.
  • Timber Hill first reported a position in Amedisys in Q4 2013 and held it in 1 quarter.
  • Timber Hill's Amedisys position peaked at $223K in Q4 2013.
  • 120 funds tracked by Wall St. Rank held Amedisys as of Q1 2014.

Based on Timber Hill's 13F filing for Q1 2014, filed 13 May 2014.